Werewolf Therapeutics (HOWL) Asset Utilization Ratio (2022 - 2026)

Werewolf Therapeutics (HOWL) has reported Asset Utilization Ratio for 5 consecutive years, with 0.51 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Asset Utilization Ratio rose 340290.62% year-over-year to 0.51 in Q2 2026; TTM through Jun 2026 was 0.51, a 340290.62% increase from a year earlier, with the FY2024 full-year figure at 0.01, down 89.42% from the prior year.
• Asset Utilization Ratio was 0.51 for Q2 2026 at Werewolf Therapeutics, up from 0.0 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.51 in Q2 2026 and troughed at 0.0 in Q2 2025.
• A 5-year average of 0.09 and a median of 0.06 in 2024 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio sank 99.73% in 2025 and surged 340290.62% in 2026, its largest moves.
• Over 5 years, Asset Utilization Ratio stood at 0.1 in 2022, then grew by 15.17% to 0.11 in 2023, then tumbled by 87.47% to 0.01 in 2024, then sank by 98.78% to 0.0 in 2025, then surged by 293254.83% to 0.51 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.51 (Q2 2026), 0.0 (Q3 2025), and 0.0 (Q2 2025), per Business Quant data.